Considering the optimal treatment strategy for patients with genetically high-risk CLL

The CLL Treatment Infection Model: identifying patients with CLL at high risk of infectionsПодробнее

Selecting the best treatment option in CLLПодробнее

The Importance of More Thoughtful Treatment Strategies in High-Risk CLLПодробнее

The latest CLL treatments and therapies with Dr Jan BurgerПодробнее

CLL: Optimal approaches for patients with deletion 17pПодробнее

Treatment options for the young CLL patient with deletion 17p: Do they need a different approach?Подробнее

Defining high-risk CLL: known and emerging mutationsПодробнее

Optimizing Treatment Strategies for Patients With CLLПодробнее

Outcomes in high-risk CLL patients following fixed-duration treatment with ibrutinib plus venetoclaxПодробнее

Which CLL Treatment Is Right for You? What You Need to KnowПодробнее

Ven-based regimens for R/R CLL and considering an MRD-guided strategyПодробнее

A potential role for CAR-T therapy in patients with high-risk CLLПодробнее

Factors to consider in frontline and relapsed CLL before treatmentПодробнее

Considering patient preference when selecting between continuous and time-limited therapy in CLLПодробнее

Finding Treatment Synergy in CLLПодробнее

Customizing Care in CLL With BTK InhibitorsПодробнее

The definition of high-risk CLLПодробнее

Novel Treatment Options in CLLПодробнее

Optimizing Frontline Therapy Selection and Follow-Up in CLLПодробнее